Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer

BACKGROUND: Renal cell carcinoma (RCC) is a malignant disease that demonstrates resistance to standard chemotherapeutic agents. Yet Active immunization using genetically modified dendritic cells holds promise for the adjuvant treatment of malignancies to eradicate or control residual disease. Cytoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Danhong, Zhang, Bin, Gao, Haiyan, Ding, Guoliang, Wu, Qiong, Zhang, Jinchao, Liao, Li, Chen, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997215/
https://www.ncbi.nlm.nih.gov/pubmed/24720900
http://dx.doi.org/10.1186/1471-2407-14-251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997215/
https://www.ncbi.nlm.nih.gov/pubmed/24720900
http://dx.doi.org/10.1186/1471-2407-14-251

Ejemplares similares